BioSpace News Archive

Sunshine Biopharma, Inc., a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, announced that it has filed its 2022 second quarter report with the Securities and Exchange Commission.

LenioBio GmbH, the German life science biotech offering a disruptive protein manufacturing technology, today announced the appointment of Mr. Jasper Levink to its Leadership Team in the role of Chief Business Officer.

Amgen (NASDAQ: AMGN) and ChemoCentryx, Inc., today announced that the companies have entered into a definitive agreement under which Amgen will acquire ChemoCentryx for $52 per share in cash, representing an enterprise value of approximately $3.7 billion.

Galmed Pharmaceuticals Ltd. provides today a business update and reports financial results for the three and six months ended June 30, 2022.

Biostage, Inc.today announced that it will release Q2 2022 financial results on August 4, 2022 and host a conference call and webcast on August 5, 2022 at 9:00 AM ET to discuss financial results and business updates for the second-quarter 2022.

Endologix LLC , a privately held global medical device company dedicated to improving patients’ lives with innovative interventional treatments for vascular disease, announced that is has received CE Mark Certification under the new EU Medical Devices Regulation [EU-MDR [(Regulation (EU) 2017/745)] for its AFX2 Endovascular AAA System.

Xentria Inc., a biotech company focused on developing novel therapeutics to address unmet clinical needs, made key leadership appointments, naming Dr. Robert Baughman as Lead Scientific Advisor and Kirsten Anderson as Chief Operating Officer.

DiaMedica Therapeutics Inc. today announced that its second quarter 2022 financial results will be released after the markets close on Wednesday, August 10 th . DiaMedica will host a live conference call on Thursday, August 11th at 7:00 AM Central Time to provide a business update.

Athersys, Inc. announces today its engagement with Ankura Consulting Group, LLC and the appointment of Kasey Rosado as the Company’s interim Chief Financial Officer.

Fulgent Genetics, Inc. today announced it has launched a test for monkeypox that leverages the U.S. Centers for Disease Control and Prevention’s (CDC) orthopoxvirus test.